Pfizer Ltd. — Regulatory Filings 2024

May 17, 2024

==> picture [100 x 41] intentionally omitted <==

Pfizer Limited

The Capital, 1802/1901, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051. Tel : +91 22 6693 2000 Fax : +91 22 2654 0274

May 17, 2024

The Corporate Relationship Dept.

BSE Limited 1[st] Floor, P.J.Towers Dalal Street, Fort Mumbai – 400 001 Scrip Code: 500680

The Manager, Listing Dept. The National Stock Exchange of India Ltd. Exchange Plaza, 5[th] Floor, Plot No. C/1, G Block Bandra-Kurla Complex, Bandra (E) Mumbai – 400 051 Scrip Symbol: PFIZER

Dear Sirs,

Sub: Statement of Related Party Transac�ons for the half year ended March 31, 2024.

Ref.: Regula�on 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Pursuant to Regulation 23(9) of the Listing Regulations, please find enclosed, disclosure of related party transactions on a consolidated basis, in the format specified in the accounting standards for the half year ended March 31, 2024.

The said disclosure is also available on the website of the Company i.e., www.pfizerltd.co.in

Request you to please take the above on record.

Thanking you,

Yours truly,

For Pfizer Limited

Digitally signed by PRAJEET PRAJEET NAIR NAIR Date: 2024.05.17 21:46:03 +05'30'

Prajeet Nair

Director – Corporate Services & Company Secretary

CIN: L24231MH1950PLC008311 Email ID: contactus.india@pfizer.com Website: www.pfizerltd.co.in

Pfizer Limited - Statement of Related Party Transactions pursuant to Regulation 23(9) of SEBI (LODR), 2015

	Pfizer Limited - Statement of Related Party Transactions pursuant to Regulation 23(9) of SEBI (LODR), 2015	Pfizer Limited - Statement of Related Party Transactions pursuant to Regulation 23(9) of SEBI (LODR), 2015	Pfizer Limited - Statement of Related Party Transactions pursuant to Regulation 23(9) of SEBI (LODR), 2015	Pfizer Limited - Statement of Related Party Transactions pursuant to Regulation 23(9) of SEBI (LODR), 2015	Pfizer Limited - Statement of Related Party Transactions pursuant to Regulation 23(9) of SEBI (LODR), 2015	Pfizer Limited - Statement of Related Party Transactions pursuant to Regulation 23(9) of SEBI (LODR), 2015	Pfizer Limited - Statement of Related Party Transactions pursuant to Regulation 23(9) of SEBI (LODR), 2015	Pfizer Limited - Statement of Related Party Transactions pursuant to Regulation 23(9) of SEBI (LODR), 2015	Pfizer Limited - Statement of Related Party Transactions pursuant to Regulation 23(9) of SEBI (LODR), 2015
												Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter- corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Sr. no	Details of the party listed entity entering into the transaction		Details of the counter party			Type of related party transaction	Value of the related party transaction as approved by the audit committee	Remarks on approval by Audit Committee	Value of transaction during the reporting period	In case monies are due to either party as a result of the transaction		In case any financial indebtedness is incurred to make or give loans, inter- corporate deposits, advances or investments			Details of the loans, inter-corporate deposits, advances or investments
	Name	PAN	Name	PAN	Relationship of the counterparty with the listed entity or its subsidiary					Opening balance	Closing balance	Nature of indebtedness (loan/ issuance of debt/ any other etc.)	**Cost **	Tenure	Nature (loan/ advance/ inter- corporate deposit/ investment	Interest Rate (%)	Tenure	Secured/ unsecured	Purpose for which the funds will be utilised by the ultimate recipient of funds (end- usage)
1	Pfizer Limited	AAACP3334M	Pfizer Service Company BVBA, Belgium	ZZZZZ9999Z	Fellow subsidiary	Purchase of Goods & Services	235.47	On arm's length basis and in Ordinary course of business	235.47	54.99	36.55	Not Applicable
2	Pfizer Limited	AAACP3334M	Pfizer Healthcare India Private Limited	AABCO2190F	Fellow subsidiary	Service Income	1.96	On arm's length basis and in Ordinary course of business	1.96	-2.48	-1.89	Not Applicable
3	Pfizer Limited	AAACP3334M	Pfizer Products India Private Limited	AADCP8985B	Fellow subsidiary	Service Income	13.94	On arm's length basis and in Ordinary course of business	13.94	-14.31	-15.36	Not Applicable
4	Pfizer Limited	AAACP3334M	Pfizer Export B.V.	ZZZZZ9999Z	Fellow subsidiary	Service Income	1.88	On arm's length basis and in Ordinary course of business	1.88	-0.15	-1.89	Not Applicable
5	Pfizer Limited	AAACP3334M	Pfizer Worldwide Services Company	ZZZZZ9999Z	Fellow subsidiary	Service Income	41.82	On arm's length basis and in Ordinary course of business	41.82	-26.41	-28.07	Not Applicable
6	Pfizer Limited	AAACP3334M	Pfizer Products India Private Limited	AADCP8985B	Fellow subsidiary	Recovery of expense	0.14	On arm's length basis and in Ordinary course of business	0.14	0	0	Not Applicable
7	Pfizer Limited	AAACP3334M	John Wyeth & Brother Limited	AAACJ1732F	Companies holding significant influence	Recovery of expense	0.02	On arm's length basis and in Ordinary course of business	0.02	2.5	2.5	Not Applicable
8	Pfizer Limited	AAACP3334M	Pfizer East India BV	AAGCP7832A	Companies holding significant influence	Witholding tax recovery on Dividend declaration	42.74	On arm's length basis and in Ordinary course of business	42.74	0	0	Not Applicable
9	Pfizer Limited	AAACP3334M	Pfizer Products India Private Limited	AADCP8985B	Fellow subsidiary	Expenses reimbursed- ESIC payment	0	On arm's length basis and in Ordinary course of business	0	0	0	Not Applicable
10	Pfizer Limited	AAACP3334M	Mr. Pradip Shah	AAEPS0592F	Independent Director	Sitting fees	0.03	On arm's length basis and in Ordinary course of business	0.03	0	0	Not Applicable
11	Pfizer Limited	AAACP3334M	Mr. Uday Khanna	AFEPK7061E	Independent Director	Sitting fees	0.03	On arm's length basis and in Ordinary course of business	0.03	0	0	Not Applicable
12	Pfizer Limited	AAACP3334M	Mr. Sunil Lalbhai	AAFPL0691R	Independent Director	Sitting fees	0.03	On arm's length basis and in Ordinary course of business	0.03	0	0	Not Applicable
13	Pfizer Limited	AAACP3334M	Ms. Meena Ganesh	ABPPG1456L	Independent Director	Sitting fees	0.02	On arm's length basis and in Ordinary course of business	0.02	0	0	Not Applicable
14	Pfizer Limited	AAACP3334M	Pfizer Corporation Hong Kong Limited	ZZZZZ9999Z	Fellow subsidiary	Reversal of expense reimbursed	0.01	On arm's length basis and in Ordinary course of business	0.01	0	0	Not Applicable
15	Pfizer Limited	AAACP3334M	Prajeet Nair	AADPN9155G	Key Managerial Personnel	Remuneration	0.59	On arm's length basis and in Ordinary course of business	0.59	0	0	Not Applicable
16	Pfizer Limited	AAACP3334M	Samir Kazi	AJSPK0243Q	Key Managerial Personnel	Remuneration	0.11	On arm's length basis and in Ordinary course of business	0.11	0	0	Not Applicable
17	Pfizer Limited	AAACP3334M	Milind Patil	AAEPP3949B	Key Managerial Personnel	Remuneration	1.47	On arm's length basis and in Ordinary course of business	1.47	0	0	Not Applicable

18	Pfizer Limited	AAACP3334M	Meenakshi Nevatia	ABSPN7808E	Key Managerial Personnel	Remuneration	3.29	On arm's length basis and in Ordinary course of business	3.29	0	0	Not Applicable
19	Pfizer Limited	AAACP3334M	P.Rengan	APIPR6900D	Key Managerial Personnel	Remuneration	0.18	On arm's length basis and in Ordinary course of business	0.18	0	0	Not Applicable
20	Pfizer Limited	AAACP3334M	Amit Agarwal	AFUPA8030R	Key Managerial Personnel	Remuneration	0.53	On arm's length basis and in Ordinary course of business	0.53	0	0	Not Applicable
21	Pfizer Limited	AAACP3334M	S.Sridhar	AAHPS2626R	Ex-Managing Director	Remuneration	3.79	On arm's length basis and in Ordinary course of business	3.79	0	0	Not Applicable